The efficacy and safety of non-flared fully covered self expandable metalic stent for benign biliary duct stricture

The efficacy and safety of non-flared fully covered self expandable metalic stent for benign biliary duct stricture - The efficacy and safety of non-flared fully cSEMS for benign biliary duct stricture

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025027

Enrollment

Registered

2016-12-01

Start date

2016-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic benign biliary duct stricture

Interventions

fully covered self-expandable metallic stent (FCSEMS) M-intraductal

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients over 20 years old 2) patients with symptomatic benign biliary stricture caused by such as surgery, ischemia, trauma, and chronic pancreatitis 3) patients with informed consent

Exclusion criteria

Exclusion criteria: 1) Performance status < 4 2) patients be impossible to distinguish from IgG4 related disease and PSC 3) patients with severe hemorrhagic diathesis 4) patients with metal allergy 5) diameter of bile duct is 5mm or less 6) patients that the physician in charge consider not suitable for inclusion

Design outcomes

Primary

Measure	Time frame
Efficacy of non-flared FCSEMS after placement for 6 months for benign biliary duct stricture	—

Countries

Japan

Contacts

Public ContactTomohisa Iwai

Kitasato University Hospital Department of Gastroenterology

t-iwai@kitasato-u.ac.jp042-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026